S.Korea’s KOTRA to aid domestic pharmaceutical firms in Japan entry

The government-run (South) Korea Trade-Investment Promotion Agency (KOTRA) announced on Tuesday that it will hold an export consultation meeting for Korean companies wishing to enter the Japanese pharmaceutical market in conjunction with the "Convention on Pharmaceutical Ingredients (CPHI) Japan 2023", which will be held from April 19 to 21.

The consultation meeting, which will take place at Tokyo Big Sight, will be attended by more than 20 domestic companies in the fields of finished and raw pharmaceuticals, biopharmaceuticals and health functional foods.

CPHI Japan, which is celebrating its 20th anniversary this year, is Japan's leading pharmaceutical exhibition, with more than 420 exhibitors and over 200 seminars from more than 25 countries in the pharmaceutical manufacturing and distribution industry.

"The Japanese pharmaceutical market is one where local large companies are dominant," said Kim Sam-shik, head of KOTRA's Japan office. "We will actively support Korean companies' business development by quickly disseminating local information necessary for our companies to develop export channels, focusing on generic drugs in high demand locally."

Write to Mi-sun Kang at misunny@hankyung.com